Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-03-08Clinical Trial Update: Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients [NA]
An update on a clinical trial evaluating the PROCOG-SEP cognitive remediation program for people with multiple sclerosis, with the trial sta…
-
FDA approval · 2016-02-29FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for Tecfidera (dimethyl fumarate).
-
EMA safety_alert · 2016-02-26EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
EMA confirms recommendations to minimize the risk of progressive multifocal leukoencephalopathy (PML) with Tysabri (natalizumab).
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating nerispirdine in multiple sclerosis has reported on its efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial update evaluating Nerispirdine's impact on visual function in patients with multiple sclerosis, including optic neu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Evaluating Intervention Responsiveness in People With Multiple Sclerosis [NA]
A completed clinical trial evaluating intervention responsiveness in people with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: A RCT of Telephone-supported ACT in MS [Phase 3]
This entry describes a Phase 3 randomized trial evaluating telephone-supported Acceptance and Commitment Therapy for Multiple Sclerosis, wit…
-
EMA guidance · 2016-02-12Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri
The EMA published updated recommendations to minimize the risk of progressive multifocal leukoencephalopathy (PML) associated with Tysabri (…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
A completed clinical trial assessing the effects of Aubagio (teriflunomide) on brain pathology in people with multiple sclerosis over 12 mon…
-
CLINICAL_TRIALS research · 2016-02-12Clinical Trial Update: Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases
This update reports on a completed clinical trial evaluating centralized imaging readings for Chronic CerebroSpinal Venous Insufficiency (CC…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis [NA]
A completed randomized controlled trial evaluating cognitive rehabilitation in individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: [18F]PBR111 and Microglial Activation in Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating [18F]PBR111 for imaging microglial activation in multiple sclerosis was terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Progressive Muscle Relaxation Effect on Sleep Quality, Depression and Stress in People With Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial assessing whether progressive muscle relaxation improves sleep quality, depression, and stress in people with Multi…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Wii FIT Balance Board to Recording Balance Parameters in Multiple Sclerosis Subjects
This clinical trial using the Wii Fit Balance Board to record balance parameters in people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Assessing Tolerability of Avonex Intramuscular Injections [NA]
This clinical trial update reports tolerability findings for Avonex intramuscular injections in people with multiple sclerosis, with results…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: JC Virus Reactivation in Multiple Sclerosis
This update from a clinical trial discusses JC virus reactivation in people with multiple sclerosis, noting the potential risk of progressiv…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Acupuncture or MBSR for Patients With Fatigue and MS [NA]
A completed clinical trial comparing acupuncture and mindfulness-based stress reduction for fatigue in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis [Phase 2]
Extension Phase 2 study assessing safety and efficacy of Natalizumab in Japanese participants with Relapsing-Remitting Multiple Sclerosis; r…
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study [EARLY_Phase 1]
This is an early-phase, open-label, single-arm clinical trial evaluating intrathecal methotrexate in patients with progressive multiple scle…
-
FDA label_change · 2015-12-24FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
FDA approved a supplemental application for Tecfidera (dimethyl fumarate) submitted by Biogen.
-
FDA approval · 2015-12-22FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Betaseron (interferon beta-1b) from Bayer HealthCare Pharmaceuticals Inc.
-
FDA approval · 2015-12-22FDA Approved: PLEGRIDY PEN — Supplemental Application (Biogen Inc.)
The FDA approved a supplemental application for the PLEGRIDY PEN auto-injector to administer peginterferon beta-1a (Plegridy) for multiple s…
-
FDA approval · 2015-12-22FDA Approved: AVONEX — Supplemental Application (Biogen Inc.)
FDA approved Biogen's supplemental application for Avonex (interferon beta-1a), indicating a modification to the product's labeling or indic…
-
FDA approval · 2015-12-22FDA Approved: REBIF — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for REBIF (interferon beta-1a) from EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis [Phase 4]
This Phase 4 trial compared an oral prednisone taper to placebo for treating acute relapses in multiple sclerosis. The study was terminated.